Oruka Therapeutics, Inc. (ORKA)
93.61
+1.41
(+1.53%)
USD |
NASDAQ |
Sep 16, 16:00
93.61
0.00 (0.00%)
After-Hours: 20:00
Oruka Therapeutics Price to Book Value : 5.143 for Sept. 16, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 5.065 |
| September 14, 2026 | 5.270 |
| September 11, 2026 | 5.075 |
| September 10, 2026 | 5.035 |
| September 09, 2026 | 5.027 |
| September 08, 2026 | 5.181 |
| September 04, 2026 | 5.082 |
| September 03, 2026 | 4.999 |
| September 02, 2026 | 5.034 |
| September 01, 2026 | 5.060 |
| August 31, 2026 | 5.088 |
| August 28, 2026 | 5.007 |
| August 27, 2026 | 5.304 |
| August 26, 2026 | 5.463 |
| August 25, 2026 | 5.594 |
| August 24, 2026 | 5.627 |
| August 21, 2026 | 5.931 |
| August 20, 2026 | 5.761 |
| August 19, 2026 | 6.026 |
| August 18, 2026 | 6.212 |
| August 17, 2026 | 6.189 |
| August 14, 2026 | 6.100 |
| August 13, 2026 | 5.940 |
| August 12, 2026 | 5.900 |
| August 11, 2026 | 5.751 |
| Date | Value |
|---|---|
| August 10, 2026 | 5.776 |
| August 07, 2026 | 5.429 |
| August 06, 2026 | 5.407 |
| August 05, 2026 | 5.339 |
| August 04, 2026 | 5.391 |
| August 03, 2026 | 5.208 |
| July 31, 2026 | 5.302 |
| July 30, 2026 | 5.376 |
| July 29, 2026 | 4.838 |
| July 28, 2026 | 4.969 |
| July 27, 2026 | 4.955 |
| July 24, 2026 | 5.063 |
| July 23, 2026 | 5.052 |
| July 22, 2026 | 5.083 |
| July 21, 2026 | 5.182 |
| July 20, 2026 | 5.038 |
| July 17, 2026 | 5.093 |
| July 16, 2026 | 4.562 |
| July 15, 2026 | 4.760 |
| July 14, 2026 | 4.805 |
| July 13, 2026 | 4.646 |
| July 10, 2026 | 4.768 |
| July 09, 2026 | 4.849 |
| July 08, 2026 | 4.637 |
| July 07, 2026 | 4.642 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Tenax Therapeutics, Inc. | 0.5105 |
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | 8.155 |
| Century Therapeutics, Inc. | 1.453 |
| Absci Corp. | 5.597 |
Price to Book Value Related Metrics
| Price | 93.61 |
| Earnings Yield | -2.63% |
| Market Cap | 5.717B |